MedTrace Logo

Norepinephrine Transporter Imaging in Addiction Disorders

NCT01719458 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-03-02

No results posted yet for this study

Summary

In this study we propose to study 24 unmedicated abstinent alcohol dependent patients, 24 obese individuals and 24 individually matched healthy control subjects and determine Norepinephrine Transporter (NET) expression in vivo using (S,S)-\[11C\]MRB and PET.

Conditions

Interventions

DRUG

(S,S)-[11C]MRB

PET radioligand

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Marc N Potenza, MD, PhD · Yale University

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2012-07-31
Completion
2023-01-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01719458 on ClinicalTrials.gov